| Jennifer Mungari, MD | |
|
300 Technology Dr, Coal Center, PA 15423-1065 | |
| (724) 938-7466 | |
| Not Available |
| Full Name | Jennifer Mungari |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 300 Technology Dr, Coal Center, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538212436 | NPI | - | NPPES |
| 102747268 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD433850 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Pa | Uniontown, PA | Home health agency |
| Washington Hospital, The | Washington, PA | Hospital |
| Monongahela Valley Hospital | Monongahela, PA | Hospital |
| Finger Lake Health-geneva General Hospital | Geneva, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Physician Services | 6103719562 | 84 |
News Archive
Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.
Results from Oxford University's RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015.
Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
› Verified 8 days ago
| Entity Name | Cornerstone Care Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376512582 PECOS PAC ID: 7911811583 Enrollment ID: O20031118000237 |
News Archive
Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.
Results from Oxford University's RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015.
Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
› Verified 8 days ago
| Entity Name | Washington Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316917669 PECOS PAC ID: 6103719562 Enrollment ID: O20040209000011 |
News Archive
Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.
Results from Oxford University's RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015.
Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
› Verified 8 days ago
| Entity Name | Fayette Physician Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992107817 PECOS PAC ID: 3375865819 Enrollment ID: O20141211000851 |
News Archive
Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.
Results from Oxford University's RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015.
Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Mungari, MD 300 Technology Dr, Coal Center, PA 15423-1065 Ph: (724) 938-7466 | Jennifer Mungari, MD 300 Technology Dr, Coal Center, PA 15423-1065 Ph: (724) 938-7466 |
News Archive
Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.
Results from Oxford University's RECOVERY trial into existing drugs for the treatment of COVID-19 has found that dexamethasone reduced deaths by a third in ventilated coronavirus patients and by a fifth in coronavirus patients requiring oxygen. This is the first drug of its kind to be demonstrated to have a significant impact on COVID-19 mortality.
The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 100 national research and training grants totaling more than $45.6 million in the first of two grant cycles for 2015.
Baylor Plano became the first hospital in the world on Friday to merge two highly advanced technologies for atrial fibrillation therapy.
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
› Verified 8 days ago